Please review the QC test results indicated by icon below as well as clone information before placing your order.

pPsagRE1Luc

Red-shifted luciferase of Pristolycus sagulatus firefly with higher luminous intensity.

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.

Terms and conditions for distribution

In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the literature designated by the DEPOSITOR is requested (Ogoh K, Akiyoshi R, Suzuki H. 2013. Firefly luciferase. Japan patent publication 2013-138668). RECIPIENT must contact the OLYMPUS CORPORATION in the case of application for any patents or commercial use(*) based on the results from the use of the BIOLOGICAL RESOURCE. (*)Commercial use shall include: (1) incorporation of the BIOLOGICAL RESOURCE into products for sale; (2) the use of to the BIOLOGICAL RESOURCE for screening candidate compounds; (3) the use of to the BIOLOGICAL RESOURCE for quality control. The RECIPIENT of any organization including for-profit or nonprofit organizations may intend to use the BIOLOGICAL RESOURCE for basic researches with such purposes.

Ordering

Order form [Credit Card Payment]  [Bank Transfer Payment] Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word] Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us.

提供案内 (日本国内) [open/close]

提供条件	利用者は、研究成果の公表にあたって別紙に定める寄託者の指定する文献を引用する (ホタル由来ルシフェラーゼ　特開2013-138668)。利用者が本件リソースを使用して得られた研究成果に基づき特許等の申請、及び商業活動(*)を行う場合は、オリンパス株式会社と別途協議を行う。(*)商用活動とは，本件リソースが製品の一部に組み込まれる場合，本件リソースを利用して製品となる候補物を探索または製品の品質管理を行う場合等とする。そのための基礎検討の使用に関しては，営利，非営利機関等の利用者制限は定めない。
提供依頼	提供依頼書 [Word] 提供同意書 (MTA、非営利機関による非営利学術研究用)[Word] 手続きの概要は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。

Please review the QC test results indicated by icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

Reference section:

Further references such as user reports and related articles (go to bottom)

Tips

Featured content

QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.

Test sheet	RDB14361_A6Jcp1.pdf

Nucleotide sequence of a portion of this resource (if available).

Primer: Reverse2 Sequence file: RDB14361_A6Jca.seq
>D03707A3_A6Jc_3_Reverse2_F04_16_ABI24.ab1     1 ATCAGGATTA CGCCAAGCTT GCATGCCTGC AGGTCGACTC TAGAGGATCC GATGGACAAC    61 GACAAGAACA TCGTGTACGG CCCCGAGCCC TTCTACCCCG TGGATAAGGG ATCTGCCGGC   121 GCTCAGATCC ACAAGTACCT GCACCAGTAC AGCAAGCTGG GCGCCATTGC CTTCACCAAT   181 GCCCTGACCG GCGTGGACAT CACCTACGCC GAGTACTTCG ACATCACCTG TCGGCTGGGC   241 GAGGCCATGA AGAGATACGG CATCAAGGTG GACGGCCGGA TCGCCCTGTG CAGCGAGAAC   301 TGCGAAGAGT TCTTCTACCC TGTGATCGCC GGCCTGTACA TCGGAGCTGG CGTGGCCCCC   361 ACCAACGAGA TCTACACCCT GCGGGAACTG GTGCACAGCC TGGGCATCAG CAAGCCCACC   421 ATCGTGTTCA GCAGCAAGAA AGGCCTGGAC AAGGTGCTGC ATGTGCAGAA AACCGTGACC   481 TGCATCAAGA CCGTCGTGAT CCTGGACAGC AAGGTGGACT ACAAGGGCTA CGACTGCGTG   541 GAATCCTTCA TCAAGCGGTA CAACCCCCCA GGCTTCCAGG CCGCCAGCTT CAAGACCGTG   601 GAAGTGGACC GGAAAGAGCA GATCGCCCTG ATCATGAACA GCAGCGGCAG CACCGGCCTG   661 CCTAAAGGCG TGCAGCTGAC ACACGAGTGC GCCGTGACCA GATTCAGCCA CGCCAAGGAC   721 CCCATCTACG GCAACCAGGT GTCCCCTGGA ACCGCCGTGC TGACCGTGGT GCCTTTCCAC   781 CACGGCTTCG GCATGTTCAC CACCCTGGGC TATCTGGCCT GCGGCTTCAG AGTGGTCATG   841 CTGACCCGCT TCGACGAGGA AATCTTCCTG AAAACCATCC AGGACTACAA GTGCACCCTA   901 GTGATCCTGG TGCCCACCCT GTTCGGCATC CTGAGCAAGA GCAAGCTGCT GGATAAGTAC   961 GACCCTGAGC AACCCTGCTG GAAATCGCTC TGGGCGGGAG CCCCCCCCTG GTCAAAGGAG  1021 GTGTCCTGAG CCGTCGTCAG AACCGCTCCA TCTGCCCTTG CGTGCGTCAT ACTTACGAAC 1081 TGACAGAGAA CGATCG //
Primer: pUC-M13_-100 Sequence file: RDB14361_A6Jcb.seq
>D03707A3_A6Jc_3_pUC-M13_-100_E04_13_ABI24.ab1     1 GGCGGTCGAG CGAATTAAGT TGGGTACGCC AGGGTTTTCC CAGTCACGAC GTTGTAAAAC    61 GACGGCCAGT GAATTCTCAC ATCTTGCTCT TGGGCTTCAT CAGGATCTCG CGGATGGCCT   121 TGCCGTCGAT CTTGCCGGTC AGGCCCTTAG GCACTTCATC CACGAAGCGC ACGCCGGCTC   181 TCAGTCTCTT GGCGTTGGAC ACCTGTCTGG CCACGTAGTC CATGATTTCT TTCTCGGTCA   241 CGTGCTTGCC CTTTTCCAGC ACCACGACAG CCCCAGGCAG TTCGCCTGCT TCAGCATCTG   301 GCACCCCGGC CACGCCGGCA TCGATGATGT AGGGATGCTG CAGCAGCACA GATTCCAGCT   361 CGGCTGGGGG CACCTGGTAG CCCTTATACT TGATCAGGGA CTTCAGCCGG TCCACGATGA   421 AGAAGTGCTG GTCCTCGTCG TAGTAGCCGA TGTCGCCTGT GTGCAGCCAG CCGTCCTCGT   481 CGATGATCTC TCTGGTGGCC TCGGGGTTGT CCATGTAGCC CTTCATCAGC ATGGGGCCCT   541 TCACACAGAC CTCGCCCCGC TGGTTGGGGC CCAGGGTTTT CTTGGTGTCC AGGTCCACCA   601 CCTTGGCCTT GAACAGGGGC ACCACCTTTC CAGAGGCGCC AGGCTTATCG TCGCCCTCGG   661 GGGTGATGAT GATGGCGCTG GTTGTCTCTG TCAGTCCGTA GCCCTGCCGC ACGCCAGGCA   721 GGTTGAACCG TCTGGCGACG GCTTCAGACA CTTCTTTGGC CAGGGGGGCT CCGCCAGAGG   781 CGATTTCCAC CAGGTTGCTC AGGTCGTACT TATCCAGCAG CTTGCTCTTG CTCAGATGCC   841 GAACAGGGTG GGCACCAGGA TCACTAGGGT GCACTTGTAG TCCTGGATGG TTTTCAGGAA   901 GATTTCCTCG TCGAAGCGGG TCAGCATGAC CACTCTGAAG CCGGCAGGCC AGATAGCCCA   961 GGGTGGGTGA ACATGCCGAA AGCCGTGGTG GAAGGGCACC ACGTCAGCAC GGCGGGTTCC  1021 CAGGGACACC TGATTTGCCC GTAGATTGGG GTTCCTTGCG TACTGATCCT GATCACGACG 1081 CCACTCGTAT GTCCAGCTGT CCACCGTCCC T //

Please visit Sequencing and PCR primers for primer information.

References

Original, user report and related articles

2023.09.13

GNP_filter3_RDBDEP_html_230702.pl